Main Topic Area
All Topic Areas
1 - 10 of 534 more >>
Articles
1 - 1 of 1
- Statement on Generic Oxycodone Hydrochloride
Extended Release Tablets
The Food and Drug Administration today released the following statement on its approval of generic oxycodone hydrochloride extended-release tablets: Oxycodone hydrochloride extended-release products, such as OxyContin and its generic versions, are important options for the management of moderate-to-severe chronic pain, such as that associated with cancer and various other illnesses. FDA's approval of two generic oxycodone hydrochloride products should make this safe and effective medicine...
U.S. Food and Drug Administration
News
1 - 5 of 115 more >>
- NanoBio(R) Corporation Initiates Phase 2b Clinical Trial For Herpes Labialis Treatment
MedicalNewsToday - Fri, 16 Feb 2007 08:00 EST
- FDA Approves Astellas' Vaprisol(R) For The Treatment Of Hypervolemic Hyponatremia
MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST
- AndroScience Corporation Enters Clinical Stage
MedicalNewsToday - Wed, 14 Feb 2007 08:00 EST
- Topical Anaesthetic Spray Delays Ejaculation By Five Times As Long Says New Study
MedicalNewsToday - Wed, 24 Jan 2007 04:00 EST
- Transport Delivers Unprecedented Levels Of Acyclovir With Novel Five Percent Gel Formulation
MedicalNewsToday - Fri, 09 Feb 2007 08:00 EST
Clinical Trials
1 - 5 of 405 more >>
- Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering from Functional Dyspepsia
ClinicalTrials.gov Identifier: NCT00112203 - Active, not recruiting
Dyspepsia
- Long-term Safety and Efficacy of Itopride Hydrochloride in Patients Suffering from Functional Dyspepsia
ClinicalTrials.gov Identifier: NCT00110968 - Active, not recruiting
Dyspepsia
- EARTH 413: An Open-Label Study to Evaluate the Effectiveness and Safety of Donepezil Hydrochloride (Aricept) in Hispanic Patients With Mild to Moderate Alzheimer''s Disease (AD)
ClinicalTrials.gov Identifier: NCT00230568 - Active, not recruiting
Alzheimer''s Disease
- A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults
ClinicalTrials.gov Identifier: NCT00302458 - Recruiting
Healthy
- Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage
ClinicalTrials.gov Identifier: NCT00226096 - Active, not recruiting
CVA (Cerebrovascular Accident); Cerebral Hemorrhage; Intracranial Hemorrhages

Not Signed In -

